Deutsche Bank’s Core Laboratories CLB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2014
Q2
Sell
-200
Closed -$1K 5890
2014
Q1
$1K Hold
200
﹤0.01% 5426
2013
Q4
$2K Buy
+200
New +$37.2K ﹤0.01% 5167

Other funds holding CLB

Deutsche Bank's CLB Position: Q2 2026 in Review

Deutsche Bank increased its Core Laboratories (CLB) stake by 17% in Q2 2026, buying an estimated $101K and bringing the position to 47,660 shares worth $555K. The position accounts for ﹤0.01% of the portfolio, ranked #2711.

Deutsche Bank first reported a position in CLB in Q2 2013 and has held it in 53 quarters since. The position peaked at $87.8M in Q1 2016. 186 funds tracked by Wall St. Rank hold CLB as of Q2 2026.

  • Deutsche Bank held 47,660 shares of Core Laboratories worth $555K as of Q2 2026.
  • Deutsche Bank bought 7,045 Core Laboratories shares in Q2 2026, an estimated $101K.
  • Core Laboratories made up ﹤0.01% of Deutsche Bank's portfolio in Q2 2026, its #2711 holding.
  • Deutsche Bank first reported a position in Core Laboratories in Q2 2013 and has held it in 53 quarters since.
  • Deutsche Bank's Core Laboratories position peaked at $87.8M in Q1 2016.
  • 186 funds tracked by Wall St. Rank held Core Laboratories as of Q2 2026.

Based on Deutsche Bank's 13F filing for Q2 2026, filed 7 Aug 2026.